Overall rank by patents
#4,960
Across all tracked assignees
USPTO PatentsView assignee record — 70 granted patents across 22 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
Leica Biosystems Nussloch GmbH has been granted 70 US utility patents between 2015 and 2025, placing Leica Biosystems Nussloch GmbH at rank #4,960 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.0 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Leica Biosystems Nussloch GmbH is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 57.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 25 grants, compared with 45 in the 2015–2019 window — a -44% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Leica Biosystems Nussloch GmbH's 13.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Leica Biosystems Nussloch GmbH against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
Leica Biosystems Nussloch GmbH
70 patents
What this shows Leica holds 70 patents — placing it at rank #4,960 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 14 | 20.0% |
| 2016 | 8 | 11.4% |
| 2017 | 7 | 10.0% |
| 2018 | 10 | 14.3% |
| 2019 | 6 | 8.6% |
| 2021 | 1 | 1.4% |
| 2022 | 11 | 15.7% |
| 2023 | 7 | 10.0% |
| 2024 | 1 | 1.4% |
| 2025 | 5 | 7.1% |
Top 15 of 22 technology areas
Overall rank by patents
#4,960
Across all tracked assignees
57.2 out of 100
Leica Biosystems Nussloch GmbH's primary CPC class — all holders and yearly trends
See where Leica Biosystems Nussloch GmbH ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.